מלטה -
אנגלית -
Medicines Authority
erlotinib pharmascience 100 mg film coated tablets
pharmascience international ltd lampousas 1, 1095 nicosia , cyprus - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 100 mg - antineoplastic agents
מלטה -
אנגלית -
Medicines Authority
erlotinib pharmascience 150 mg film coated tablets
pharmascience international ltd lampousas 1, 1095 nicosia , cyprus - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 150 mg - antineoplastic agents
ניו זילנד -
אנגלית -
Medsafe (Medicines Safety Authority)
erlotinib (alchemy)
alchemy health limited - erlotinib hydrochloride 109.27mg equivalent to erlotinib 100mg - film coated tablet - 100 mg - active: erlotinib hydrochloride 109.27mg equivalent to erlotinib 100mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 200f280000 sodium starch glycolate - erlotinib is indicated for the first-line and maintenance treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. erlotinib is also indicated for the treatment of patients with locally advanced or metastatic nsclc who have previously received chemotherapy.
ניו זילנד -
אנגלית -
Medsafe (Medicines Safety Authority)
erlotinib (alchemy)
alchemy health limited - erlotinib hydrochloride 163.9mg equivalent to erlotinib 150mg - film coated tablet - 150 mg - active: erlotinib hydrochloride 163.9mg equivalent to erlotinib 150mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 200f280000 sodium starch glycolate - erlotinib is indicated for the first-line and maintenance treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. erlotinib is also indicated for the treatment of patients with locally advanced or metastatic nsclc who have previously received chemotherapy.
קנדה -
אנגלית -
Health Canada
apo-erlotinib tablet
apotex inc - erlotinib (erlotinib hydrochloride) - tablet - 25mg - erlotinib (erlotinib hydrochloride) 25mg - antineoplastic agents
קנדה -
אנגלית -
Health Canada
apo-erlotinib tablet
apotex inc - erlotinib (erlotinib hydrochloride) - tablet - 100mg - erlotinib (erlotinib hydrochloride) 100mg - antineoplastic agents
קנדה -
אנגלית -
Health Canada
apo-erlotinib tablet
apotex inc - erlotinib (erlotinib hydrochloride) - tablet - 150mg - erlotinib (erlotinib hydrochloride) 150mg - antineoplastic agents
בלגיה -
אנגלית -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
erlotinib eg 25 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 27,32 mg - eq. erlotinib 25 mg - film-coated tablet - 25 mg - erlotinib hydrochloride 27.32 mg - erlotinib
בלגיה -
אנגלית -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
erlotinib eg 50 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 54,63 mg - eq. erlotinib 50 mg - film-coated tablet - 50 mg - erlotinib hydrochloride 54.63 mg - erlotinib
בלגיה -
אנגלית -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
erlotinib eg 100 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 109,27 mg - eq. erlotinib 100 mg - film-coated tablet - 100 mg - erlotinib hydrochloride 109.27 mg - erlotinib